Early Expression of Autism Spectrum Disorders
Early Expression of Autism Spectrum Disorders
Spectrum Disorders
What is autism? (2013)
• A developmental behaviorally-defined
syndrome/phenotype
– Impacts social skills & communication
– Associated with narrow, rigid, repetitive
behaviors
• NOT A “DISEASE” !
• Affects the immature, developing brain
Autism: Clinical Features
• Marked heterogeneity
• Developmental disorder
Leo Kanner
Age of Onset: Parental Perception
concern:
20
– 15 months (SD=6.5)
15
Percent
• Primary concerns: 10
– Social difficulties
5
– Speech delays
0
0-2 3-4 5-6 7-8 9-10 11-12 13-14 15-16 17-18 19-20 21-22 23-24
• Why such a
Age (monhts)
– 3 to 6 months:
• Emergence of dyadic social interactions
– 6 to 9 months:
• Development of face processing skills (identity, affect, gender)
• Response to name
• Anticipatory social games
– 9 to 12 months:
• Social monitoring and imitation
• Social referencing
• Joint attention
• Poor observational/imitative
learning
• Stereotypical/idiosyncratic use of
language (e.g., echolalia, scripting)
Pretend:
Absent
Present but atypical, non-
generative
Restricted Interests and Repetitive
Behaviors
• Seeking/avoiding specific visual
stimuli (lights, motion, touch)
• Exceptional skills
– Interest in shapes, letters,
numbers
– Early recognition of signs
(“reading”)
– Good expressive vocabulary
– Great memory for movies, books
Selectively affected
areas:
Frontal lobe
Temporal lobe
Cerebellum
Amygdala
Neuropathology
• 1980: 4 cases with severe MR: cerebellar +
other brain abnormalities (Williams et al.)
• 1985-2002: Cerebellum + limbic pathology
(Bauman and Kemper)
– No major brain anomalies/lesions
– Loss of Purkinje cells in cerebellar cortex, neurons in
deep cerebellar nuclei, inferior olive
– Stunted neurons in diencephalon, amygdala
– Pathology progressive in adults compared to
children?
• 1996: brainstem malformation in one case
(Rodier et al.)
– HOXA1 gene
– Thalidomide, valproate toxicity
Autism: Hippocampal Neurons
(Bauman & Kemper 1985-1994)
24
Cortical minicolumns in cortical area 4
lamina III in autism vs control brain
Normal
control brain
Casanov
a ASD brain
2006
Stability of Early Clinical Diagnosis
Total 36 28 25 89
– Individual characteristics
(e.g., age, disorders)
0.7
0.6
% Time
0.5
0.4
0.3
0.2
0.1
0
3m 6m 9m 12m 3m 6m 9m 12m 3m 6m 9m 12m
Chronological Age
Atypical Face Processing in
Toddlers with ASD
Face Processing in Autism
• Next frontier:
– Primary or secondary impairments?
– Are other aspects of face processing affected as well?
Early Expression of ASD
• Symptoms of social dysfunction are apparent in a
majority of cases by 24 months
• Next frontier:
– ASD in the 1st year
– Parsing heterogeneity of syndrome expression
Goals of Intervention
• Stop looking for a cure
• Stop striving for ‘normality’
• Think adaptation, i.e., fixing, circumventing
• Consider the individual’s needs
• Tolerate socially acceptable differences
• Welcome the unique contributions of some
Where to go: biology
• Elucidate pathophysiology, i.e., what goes on
in the brain (neurotransmitters,
neuromodulators, epilepsy, etc…)
• Pathophysiology more likely to lead to new
drugs than genetics
• Elucidate basis of autistic regression
• Devise a rational treatment for autistic
regression
Where to go: genetics
• In the clinic:
– Limited referral based on family history &
phenotype
– Probability of a specific genetic diagnosis low
– Always discuss recurrence risk !
– Lack of prenatal diagnosis unless etiology
known
• For research (paid for by research
funds !)
– Strongly encourage enrollment in a funded
comprehensive study, but
Where to go: medical
interventions
• Discourage use of medical/dietary treatments
that have no reasonable rationale
• Urgent need to evaluate efficacy of medical
and educational interventions in well studied
subgroups of individuals